“Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”, J of Skin, vol. 3, p. S37, Nov. 2019, doi: 10.25251/skin.3.supp.37.